We hypothesized that NGF signaling and downstream pathways are highly relevant to the pathophysiological mechanism of DM1, i.e., NGF, NTRK1, RhoA, ROCK1/2, and DAG novel putative DM1 targets. The gene discussed is RHOA; the disease is myotonic dystrophy type 1.